Impact of hepatectomy for huge solitary hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 107, Issue 4, 2013, Pages 408-413

  Ariizumi, Shun Ichi ^a   Kotera, Yoshihito ^a   Takahashi, Yutaka ^a   Katagiri, Satoshi ^a   Yamamoto, Masakazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

HCC; hepatic resection; large

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR THROMBUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84874234692     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23226     Document Type: Article

References (24)

1. Lee NH, Chau GY, Lui WY, et al.: Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 1998; 85: 1654-1657.
2. Yeh CN, Lee WC, Chen MF:, Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: Two decades of experience at Chang Gung Memorial Hospital. Ann Surg Oncol 2003; 10: 1070-1076.
3. Mok KT, Wang BW, Lo GH, et al.: Multimodality management of hepatocellular carcinoma larger than 10 cm. Am Coll Surg 2003; 197: 730-738.
4. Chen XP, Qiu FZ, Wu ZD, et al.: Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg 2004; 91: 322-326.
5. Nagano Y, Tanaka K, Togo S, et al.: Efficacy of hepatic resection for hepatocellular carcinoma larger than 10 cm. World J Surg 2005; 29: 66-71.
6. Pawlik TM, Poon RT, Abdalla EK, et al.: Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140: 450-458.
7. Liau KH, Ruo L, Shia J, et al.: Outcome of primary hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 2005; 104: 1948-1955.
8. Pandey D, Lee KH, Wai CT, et al.: Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007; 14: 2817-2823.
9. Shah SA, Wei AC, Cleary SP, et al.: Prognosis and results after resection of very large (≥10 cm) hepatocellular carcinoma. J Gastrointest Surg 2007; 11: 589-595.
10. Lee SG, Hwang S, Jung JP, et al.: Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007; 94: 320-326.
11. Vauthey JN, Lauwers GY, Esnaola NF, et al.: Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20: 1527-1536.
12. International Union Against Cancer (UICC): TNM classification of malignant tumours, 6th edition. New York, NY: Wiley-Liss; 2002. pp. 81-83.
13. Llovet JM, Bru C, Bruix J:, Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-337.
14. Bruix J, Sherman M:, Practice Guidelines Committee. American Association for the Study of Liver Disease. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
15. Makuuchi M, Kokudo N:, Clinical practice guidelines for hepatocellular carcinoma: The first evidence based guidelines from Japan. World J Gastroenterol 2006; 12: 828-829.
16. Takasaki K, Kobayashi S, Tanaka S, et al.: Highly anatomically systematized hepatic resection with Glissonean sheath cord transection at the hepatic hilus. Int Surg 1990; 75: 73-77.
17. Takasaki K:, Glissonean pedicle transection method for hepatic resection: A new concept of liver segmentation. J Hepatobiliary Pancreat Surg 1998; 5: 286-291.
18. Llovet JM, Real MI, Montana X, et al.: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734-1739.
19. Poon RT, Ngan H, Lo CM, et al.: Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000; 73: 109-111.
20. Zhong C, Guo RP, Li JQ, et al.: A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135: 1437-1445.
21. Nagano H, Sakon M, Eguchi H, et al.: Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology 2007; 54: 172-179.
22. Kamiyama T, Nakanishi K, Yokoo H, et al.: Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Int J Clin Oncol 2007; 12: 363-368.
23. Kishi K, Shikata T, Hirohashi S, et al.: Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases. Cancer 1983; 51: 542-548.
24. Hsu HC, Sheu JC, Lin YH, et al.: Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer 1985; 56: 672-680.